Antibacterial and Anticancer Activities of Insulicolides from Streptomyces sp. UL09; An Endophyte of Ulva rigida C. Agardh
- 1Silpakorn University
Abstract
Marine macroalgae host endophytic microbial communities that serve as valuable reservoirs for drug discovery. In this study, the endophytic actinomycete Streptomyces sp. UL09 was isolated from the internal thallus tissues of the green macroalga Ulva rigida C. Agardh. Fermentation of strain UL09 yielded the nitrobenzoyl sesquiterpenoids insulicolide B (1.63 mg/L) and insulicolide C (1.79 mg/L). The planar structures of compounds 1 and 2 were assigned as insulicolides B and C, respectively, via spectroscopic analysis and comparison with literature data. In vitro bioassays revealed moderate activity against Gram-positive bacteria (MIC 128-512 g/mL), including MRSA Sp3 (MIC 128-256 g/mL). These compounds exhibited cytotoxic activity against human cancer cell lines (HeLa, HepG2, and MDA-MB-231) with IC50 values ranging from 34.35 to 142.64 g/mL. Both compounds demonstrated lower cytotoxicity toward non-malignant Vero cells. Molecular docking simulations predicted that both metabolites target the catalytic ATP-binding cleft of human Polo-like kinase 1 (Plk1), with insulicolide B displaying a favorable docking score ({Delta}G = -9.273 kcal/mol). Furthermore, pkCSM predicted high intestinal absorption and no alerts for the assessed toxicity endpoints. These findings establish Streptomyces sp. UL09 as a viable alternative biological source of insulicolides B and C, highlighting their potential as leads for oncology applications.
Related
- Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities
- Developmental Dynamics of Bioactive Composition and Biological Activities of Methanolic Extracts from Orange (Citrus sinensis) Peel: Comprehensive Metabolite Profiling, Antioxidant Capacity, and Antibacterial Activity
- Molecular mechanisms involved in the anticancer activities of probiotics and postbiotics.
- Carbon nanoparticles synergistically improve drought tolerance and nutraceutical innovation in okra (Abelmoschus esculentus L.): Antioxidant, antibacterial, and anti-fibrotic activities enhanced via flavonoid accumulation.
- Phytochemical analyses, antimicrobial, antioxidant and anticancer activities of endophytic fungi from leaves of Reseda pruinosa
BibTeX
@misc{taechowisan2026antibacterial,
title = {{Antibacterial and Anticancer Activities of Insulicolides from Streptomyces sp. UL09; An Endophyte of Ulva rigida C. Agardh}},
author = {T. Taechowisan and T. Chuen-Im and W. S. Phutdhawong},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.20.751976},
url = {https://www.biorxiv.org/content/10.64898/2026.09.20.751976v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Antibacterial and Anticancer Activities of Insulicolides from Streptomyces sp. UL09; An Endophyte of Ulva rigida C. Agardh
AU - T. Taechowisan
AU - T. Chuen-Im
AU - W. S. Phutdhawong
PY - 2026
DA - 2026/09/20
PB - bioRxiv
DO - 10.64898/2026.09.20.751976
UR - https://www.biorxiv.org/content/10.64898/2026.09.20.751976v1
AB - Marine macroalgae host endophytic microbial communities that serve as valuable reservoirs for drug discovery. In this study, the endophytic actinomycete Streptomyces sp. UL09 was isolated from the internal thallus tissues of the green macroalga Ulva rigida C. Agardh. Fermentation of strain UL09 yielded the nitrobenzoyl sesquiterpenoids insulicolide B (1.63 mg/L) and insulicolide C (1.79 mg/L). The planar structures of compounds 1 and 2 were assigned as insulicolides B and C, respectively, via spectroscopic analysis and comparison with literature data. In vitro bioassays revealed moderate activity against Gram-positive bacteria (MIC 128-512 g/mL), including MRSA Sp3 (MIC 128-256 g/mL). These compounds exhibited cytotoxic activity against human cancer cell lines (HeLa, HepG2, and MDA-MB-231) with IC50 values ranging from 34.35 to 142.64 g/mL. Both compounds demonstrated lower cytotoxicity toward non-malignant Vero cells. Molecular docking simulations predicted that both metabolites target the catalytic ATP-binding cleft of human Polo-like kinase 1 (Plk1), with insulicolide B displaying a favorable docking score ({Delta}G = -9.273 kcal/mol). Furthermore, pkCSM predicted high intestinal absorption and no alerts for the assessed toxicity endpoints. These findings establish Streptomyces sp. UL09 as a viable alternative biological source of insulicolides B and C, highlighting their potential as leads for oncology applications.
ER -